Cefepime – Injection products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacterales |
≤2 |
4-8a |
≥16 |
≥25 |
19-24a |
≤18 |
Pseudomonas aeruginosa b |
≤8 |
- |
≥16 |
≥18 |
- |
≤17 |
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp β- Hemolytic Group |
M100 standard is recognized |
|||||
Streptococcus spp Viridans Group |
M100 standard is recognized |
S = Susceptible; I = Intermediate; R = Resistant
a For isolates of Enterobacterales with intermediate susceptibility, use a dose of 2g every 8 hours in patients with normal renal function.
b For Pseudomonas aeruginosa, use a dose of 2 g IV every 8 hours in patients with normal renal function.
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp
Other Non-Enterobacterales
Haemophilus influenzae and Haemophilus parainfluenzae
Neisseria gonorrhoeae